Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
Research center
Instituto de Química Avanzada de Cataluña
Barcelona, EspañaPublications in collaboration with researchers from Instituto de Química Avanzada de Cataluña (9)
2023
-
Assessment of anti-malondialdehyde-acetaldehyde antibody frequencies in rheumatoid arthritis with new data from two independent cohorts, meta-analysis, and meta-regression
Arthritis Research and Therapy, Vol. 25, Núm. 1
-
Semisynthetic Pneumococcal Glycoconjugate Nanovaccine
Bioconjugate Chemistry, Vol. 34, Núm. 9, pp. 1563-1575
2021
-
Biodistribution of 68/67Ga-radiolabeled sphingolipid nanoemulsions by pet and spect imaging
International Journal of Nanomedicine, Vol. 16, pp. 5923-5935
2020
-
Biocompatible Nanovector of siRNA Consisting of Arginine-Based Cationic Lipid for Gene Knockdown in Cancer Cells
ACS Applied Materials and Interfaces, Vol. 12, Núm. 31, pp. 34536-34547
-
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
Journal of Medicinal Chemistry, Vol. 63, Núm. 17, pp. 9360-9390
-
Protein expression knockdown in cancer cells induced by a gemini cationic lipid nanovector with histidine-based polar heads
Pharmaceutics, Vol. 12, Núm. 9, pp. 1-22
2018
-
Ghrelin Causes a Decline in GABA Release by Reducing Fatty Acid Oxidation in Cortex
Molecular Neurobiology, Vol. 55, Núm. 9, pp. 7216-7228
2015
-
New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies
MedChemComm, Vol. 6, Núm. 6, pp. 1178-1185
2010
-
Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease
Progress in Lipid Research, Vol. 49, Núm. 4, pp. 316-334